share_log

These 18 Clinical Trials Could Shape The Future Of The Psychedelics Industry

These 18 Clinical Trials Could Shape The Future Of The Psychedelics Industry

這18項臨牀試驗可能塑造迷幻藥行業的未來
Benzinga Real-time News ·  2022/06/02 15:52
In the nascent industry of medical psychedelics, drug development is the name of the game.
在新興的醫療迷幻劑行業,藥物開發是遊戲的名稱。
This subset of biotech, poised to become a $100 billion industry according to Canaccord Genuity, bases its success on the regulation and approval of scheduled psychoactive substances for mental health and other health indications.
生物技術的這個子集, 有望成為價值1000億美元的行業根據卡納科特·格納奇,其成功的基礎是對用於精神健康和其他健康指徵的表列精神活性物質進行監管和批准。
While there are over 100 different clinical trials looking at the therapeutic potential of drugs like ecstasy, LSD, ketamine and magic mushrooms currently underway, our colleagues at Insider identified 18 key trials "that could shape the future of the psychedelics industry by providing crucial information about whether compounds such as psilocybin and MDMA work...
雖然有100多種不同的臨牀試驗研究了目前正在進行的搖頭丸、LSD、氯胺酮和神奇蘑菇等藥物的治療潛力,我們...
声明:本內容僅用作提供資訊及教育之目的,不構成對任何特定投資或投資策略的推薦或認可。 更多信息
    搶先評論